Company
bionode
Claim, correct or request removal
Record updated 20 September 2026
About
Through developing a first-in-class smartlens system that rapidly reduces intraocular pressure in glaucoma patients, bionode seeks to enhance glaucoma therapy and improve patient outcomes. The smartlens - called IOPTx - has proven success in clinical trials, reducing intraocular pressure in patients by 38%.
Loading relationship preview